Spero Therapeutics, Inc. (SPRO)

2.30 -0.10 (-4.17%) USD  |  NASDAQ  |  Feb 20, 16:00
2.295 0.00 (0.00%) Pre-Market: 20:00
More

Spero Therapeutics Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Cassava Sciences, Inc. Upgrade
Alpha Teknova, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade